These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 17266927

  • 41. NFATc2 is an intrinsic regulator of melanoma dedifferentiation.
    Perotti V, Baldassari P, Molla A, Vegetti C, Bersani I, Maurichi A, Santinami M, Anichini A, Mortarini R.
    Oncogene; 2016 Jun 02; 35(22):2862-72. PubMed ID: 26387540
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Mitf silencing cooperates with IL-12 gene transfer to inhibit melanoma in mice.
    Nakai N, Kishida T, Hartmann G, Katoh N, Imanishi J, Kishimoto S, Mazda O.
    Int Immunopharmacol; 2010 Apr 02; 10(4):540-5. PubMed ID: 20074674
    [Abstract] [Full Text] [Related]

  • 47. Interleukins 1alpha and 1beta secreted by some melanoma cell lines strongly reduce expression of MITF-M and melanocyte differentiation antigens.
    Kholmanskikh O, van Baren N, Brasseur F, Ottaviani S, Vanacker J, Arts N, van der Bruggen P, Coulie P, De Plaen E.
    Int J Cancer; 2010 Oct 01; 127(7):1625-36. PubMed ID: 20099279
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study.
    Nazarian RM, Prieto VG, Elder DE, Duncan LM.
    J Cutan Pathol; 2010 Apr 01; 37 Suppl 1():41-7. PubMed ID: 20482674
    [Abstract] [Full Text] [Related]

  • 51. The cleavage of microphthalmia-associated transcription factor, MITF, by caspases plays an essential role in melanocyte and melanoma cell apoptosis.
    Larribere L, Hilmi C, Khaled M, Gaggioli C, Bille K, Auberger P, Ortonne JP, Ballotti R, Bertolotto C.
    Genes Dev; 2005 Sep 01; 19(17):1980-5. PubMed ID: 16140982
    [Abstract] [Full Text] [Related]

  • 52. Novel MITF targets identified using a two-step DNA microarray strategy.
    Hoek KS, Schlegel NC, Eichhoff OM, Widmer DS, Praetorius C, Einarsson SO, Valgeirsdottir S, Bergsteinsdottir K, Schepsky A, Dummer R, Steingrimsson E.
    Pigment Cell Melanoma Res; 2008 Dec 01; 21(6):665-76. PubMed ID: 19067971
    [Abstract] [Full Text] [Related]

  • 53. Suppression of tumorigenic and metastatic potentials of human melanoma cell lines by mutated (143 Val-Ala) p53.
    Rauth S, Green A, Kichina J, Shilkaitis A.
    Br J Cancer; 1998 Jun 01; 77(12):2215-22. PubMed ID: 9649136
    [Abstract] [Full Text] [Related]

  • 54. Dasatinib Stimulates Its Own Mechanism of Resistance by Activating a CRTC3/MITF/Bcl-2 Pathway in Melanoma with Mutant or Amplified c-Kit.
    Sabbah M, Krayem M, Najem A, Sales F, Miller W, Del Rincon S, Awada A, Ghanem GE, Journe F.
    Mol Cancer Res; 2021 Jul 01; 19(7):1221-1233. PubMed ID: 33741716
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Expression of microphthalmia-associated transcription factor (MITF), which is critical for melanoma progression, is inhibited by both transcription factor GLI2 and transforming growth factor-β.
    Pierrat MJ, Marsaud V, Mauviel A, Javelaud D.
    J Biol Chem; 2012 May 25; 287(22):17996-8004. PubMed ID: 22496449
    [Abstract] [Full Text] [Related]

  • 58. The tumor suppressor HINT1 regulates MITF and β-catenin transcriptional activity in melanoma cells.
    Genovese G, Ghosh P, Li H, Rettino A, Sioletic S, Cittadini A, Sgambato A.
    Cell Cycle; 2012 Jun 01; 11(11):2206-15. PubMed ID: 22647378
    [Abstract] [Full Text] [Related]

  • 59. Microphthalmia-associated transcription factor suppresses invasion by reducing intracellular GTP pools.
    Bianchi-Smiraglia A, Bagati A, Fink EE, Moparthy S, Wawrzyniak JA, Marvin EK, Battaglia S, Jowdy P, Kolesnikova M, Foley CE, Berman AE, Kozlova NI, Lipchick BC, Paul-Rosner LM, Bshara W, Ackroyd JJ, Shewach DS, Nikiforov MA.
    Oncogene; 2017 Jan 05; 36(1):84-96. PubMed ID: 27181209
    [Abstract] [Full Text] [Related]

  • 60. Mutated MITF-E87R in Melanoma Enhances Tumor Progression via S100A4.
    Nordlinger A, Dror S, Elkahloun A, Del Rio J, Stubbs E, Golan T, Malcov H, Pricket TD, Cronin JC, Parikh S, Labes S, Thomas L, Yankovitz G, Tabach Y, Levy C, Samuels Y, Khaled M.
    J Invest Dermatol; 2018 Oct 05; 138(10):2216-2223. PubMed ID: 29679610
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.